Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H D Preisler

Showing results (121-130 of 271) with videos related to

Pageof 28
Sort By:
Leukemia Research|January 1, 1981
DNA damage in AML cell exposed to adriamycin; correlations with clinical response to therapyH S Schwartz, H D Preisler, P M Kanter
Leukemia Research|January 1, 1988
Sustained viability of acute myelogenous leukemia cells in liquid suspension culture correlates with occurrence of differentiationM R Baer, X Z Gao, H D Preisler
Leukemia Research|April 1, 1997
Cytokines, molecular biological abnormalities, and acute myelogenous leukemiaH D Preisler, S Bi, P Venugopal, et al.
Haematologica|May 1, 1992
The CD34 hemopoietic progenitor cell associated antigen: biology and clinical applicationsF Silvestri, S Banavali, M Baccarani, et al.
Anticancer Research|July 1, 1989
The effects of cytosine arabinoside and GM-CSF in leukemic cells in vitroX Z Gao, M Y Yin, H D Preisler
Cancer|November 1, 1970
Gastrointestinal "sterilization" in the treatment of patients with acute leukemiaH D Preisler, I M Goldstein, E S Henderson
Seminars in Oncology|June 1, 1985
Pharmacokinetics and cellular determinants of response to 1-beta-arabinofuranosylcytosine (ara-C)C M Riva, Y M Rustum, H D Preisler
The American Journal of Medicine|September 1, 1971
Anti-Candida antibodies in patients with acute leukemia. A prospective studyH D Preisler, H F Hasenclever, E S Henderson
Seminars in Oncology|June 1, 1985
In vitro and in vivo assessment of sensitivity to ara-C in myeloid leukemiasA Raza, K Ucar, H D Preisler, et al.
American Journal of Hematology|January 1, 1987
Analysis of cell cycle characteristics and course of the disease in ANLLA Raza, Y Maheshwari, W Brereton, et al.
Pageof 28

Showing results (121-130 of 271) with videos related to

Sort By:
Pageof 28
Leukemia Research|January 1, 1981
DNA damage in AML cell exposed to adriamycin; correlations with clinical response to therapyH S Schwartz, H D Preisler, P M Kanter
Leukemia Research|January 1, 1988
Sustained viability of acute myelogenous leukemia cells in liquid suspension culture correlates with occurrence of differentiationM R Baer, X Z Gao, H D Preisler
Leukemia Research|April 1, 1997
Cytokines, molecular biological abnormalities, and acute myelogenous leukemiaH D Preisler, S Bi, P Venugopal, et al.
Haematologica|May 1, 1992
The CD34 hemopoietic progenitor cell associated antigen: biology and clinical applicationsF Silvestri, S Banavali, M Baccarani, et al.
Anticancer Research|July 1, 1989
The effects of cytosine arabinoside and GM-CSF in leukemic cells in vitroX Z Gao, M Y Yin, H D Preisler
Cancer|November 1, 1970
Gastrointestinal "sterilization" in the treatment of patients with acute leukemiaH D Preisler, I M Goldstein, E S Henderson
Seminars in Oncology|June 1, 1985
Pharmacokinetics and cellular determinants of response to 1-beta-arabinofuranosylcytosine (ara-C)C M Riva, Y M Rustum, H D Preisler
The American Journal of Medicine|September 1, 1971
Anti-Candida antibodies in patients with acute leukemia. A prospective studyH D Preisler, H F Hasenclever, E S Henderson
Seminars in Oncology|June 1, 1985
In vitro and in vivo assessment of sensitivity to ara-C in myeloid leukemiasA Raza, K Ucar, H D Preisler, et al.
American Journal of Hematology|January 1, 1987
Analysis of cell cycle characteristics and course of the disease in ANLLA Raza, Y Maheshwari, W Brereton, et al.
Pageof 28